期刊文献+

再谈他汀类药物与新发糖尿病的关系及防治 被引量:2

Revaluation of the relationship,use of statins for new onset diabetes
原文传递
导出
摘要 他汀类药物是一类强效降低密度脂蛋白胆固醇药物。控制血脂对预防心血管疾病风险极为重要。及早启动他汀类药物治疗,对降低糖尿病心血管风险意义重大。然而,多个随机对照试验荟萃分析后显示他汀类药物可能导致新发糖尿病,相关机制仍不明确。 Statins, as a kind of most potent lipid-lowering medicine, have being an essential drug of CVD prevention strategies. However, many meta-analyses of RCTs showed that statins may induce new onset diabetes, the related mechanisms are still unknown.
出处 《临床药物治疗杂志》 2013年第3期24-27,共4页 Clinical Medication Journal
关键词 他汀类药物 新发糖尿病 防治 Statins New onset diabetes Prevention and treatment
  • 相关文献

参考文献21

  • 1Introduction:The American Diabetes Association's(ADA)evidence-based practice guidelines,standards,and related recommendations and documents for diabetes care[J].Diabetes Care,2012,35(Suppl):S1-S2.
  • 2Greqq EW,Chen H,Wagenknecht LE,et al.Association of an intensive lifestyle intervention with remission of type2diabetes[J].JAMA,2012,308(23):2489-2496.
  • 3Kearney PM,Blackwell L,Collins R,et al.Efficacy of cholesterol-lowering therapy in18,686people with diabetes in14randomised trials of statins:a meta-analysis[J].Lancet,2008,371(9607):117-125.
  • 4Deshmukh HA,Colhoun HM,Johnson T,et al.Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy:importance of Lp(a)[J].J lipid Res,2012,53(5):1000-1011.
  • 5Nichols GA,Joshua-Gotlib S,Parasuraman S.Independent Contribution of A1C,SBP,and LDL-C Control to Risk of Cardiovascular Disease Hospitalizations in Type2Diabetes:An Observational Cohort Study[J].J Gen Intern Med,2013,28(5):691-697.
  • 6Sattar N,Preiss D,Murray HM,et al.Statins and risk of incident diabetes:a collaborative meta-analysis of randomised statin trials[J].Lancet,2010,375(9716):735-742.
  • 7McEvoy JW.Statin therapy dose and risk of new-onset diabetes[J].JAMA,2011,306(12):1325-1326.
  • 8Reiner,Catapano AL,De Backer G,et al.ESC/EAS Guidelines for the management of dyslipidaemias[J].Rev Esp Cardiol,2011,64(12):1168.e1-1168.e60.
  • 9Jukema JW,Cannon CP,de Craen AJ,et al.The Controversies of Statin Therapy Weighing the Evidence[J].J Am Coll Cardiol,2012,60(10):875-881.
  • 10Ridker PM,Danielson E,Fonseca FA,et al.Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein[J].N Engl J Med,2008,359(21):2195-2207.

同被引文献35

  • 1顾东风,Jiang He,吴锡桂,段秀芳,姚崇华,王家良,Kristi Reynolds,Chung-Shiuan Chen,Michael J.Klag,Paul K.Whelton.中国成年人主要死亡原因及其危险因素[J].中国慢性病预防与控制,2006,14(3):149-154. 被引量:75
  • 2孟立军,王文英,刁树玲.阿托伐他汀的临床应用[J].实用心脑肺血管病杂志,2007,15(4):325-326. 被引量:11
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5219
  • 4王妍,张梅,柳秋实,等.他汀类药物防治心血管疾病的研究进展[J].中国老年医学杂志,2012,5(32):1989-1992.
  • 5Melgs J B,D' Agostino RB, Wilson PW, et al. Risk variable cluste ring in the insulin resistance syndrome[J]. Diabetes, 1997,46 (10) :1594- 1600.
  • 6Psyroglannis AJ. Insulin resistance hyperinsulinemia and hyper triglyeeridemia in patients with coronary artery disease independ ent of obesity[J].Angiology, 1998,49:607 - 612.
  • 7Cingozbay BY, Top C, Keskin O, et al. Effects ot Fluvastatin treatment on insulin sensitivity in patients with hyperlipidaemia [J].J Inter Med Res,2002,30:21 -25.
  • 8Ference BA, Yoo W, Alesh L, et al. Effect of long - term exposure to lower low - density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease[J]. J Am Coil Cardiol, 2012,60(25) :2631 - 2639.
  • 9Serruys PW,Fluvastatin for prevention of cardiac events follow- ing successful first percutaneous coronary intervention[J]. JA MA,2002,287(24) :3215 - 3222.
  • 10Nasu K, Tsnchikane E, Katoh o, et al. Effect of fluvastatin on progression of coronary atherosclerotie plaque evaluated by virtu al histology intravaseular ultrasound[J]. JACC Cardiovasc In- terv,2009,2(7) ..689 - 696.

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部